Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
doi: 10.1016/S0140-6736(20)32511-3 Summary Keywords chronic liver disorder, metabolic syndrome, non-alcoholic fatty liver disease, oxidative stress, oral glutathione Citation Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV and Di Sabatino A (2023) Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease
Five stars
The binding site for the hydrophobic electrophiles, or H site, is located immediately adjacent to the G site and forms part of the solvent-exposed cleft between both domains
Further supporting this, Lock and colleagues demonstrated that glutathione protects against 2-chloropropionic acid (CPA)-induced cerebellar toxicity by preserving thiol redox equilibrium and potentially interacting with NMDA receptor-mediated pathways
Recent human data also suggest liposomal glutathione can outperform plain oral glutathione in uptake and systemic availability
Yamada, Hideto, et al
US$ 29.85
US$ 26.72
US$ 21.69
US$ 21.64
US$ 27.47
